Intentional wedge resection versus segmentectomy for ≤2 cm ground-glass-opacity-dominant non-small cell lung cancer: a real-world study using inverse probability of treatment weighting
Open Access
- 21 March 2024
- journal article
- research article
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (7) , 4231-4239
Abstract
Background: Whether wedge resection is oncological suitable for ground glass opacity (GGO)-dominant non-small cell lung cancer (NSCLC) ≤2 cm is still debatable. The aim of this study is to investigate the short-term and long-term outcomes of intentional wedge resection and segmentectomy for those patients. Materials and Methods: This was a real-world study from one of the largest thoracic surgery centers in West China. Patients who underwent intentional wedge resection or segmentectomy for ≤2 cm CTR (consolidation-to-tumor) ≤0.5 NSCLC were consecutively included between December 2009 and December 2018. Data were prospectively collected and retrospectively reviewed. Inverse probability of treatment weighting (IPTW) was used to balance baseline characteristics. Long-term outcomes, including overall survival (OS), recurrence-free survival (RFS), and lung cancer-specific survival (LCSS), were analyzed using Cox proportional model. Results: A total of 1209 patients were included (497 in the wedge resection group, 712 in the segmentectomy group). Compared to segmentectomy, wedge resection had a significantly lower rate of complications (3.8 vs. 7.7%, P=0.008), a shorter operating time (65 min vs. 114 min, PPP=0.270), 5-year RFS (98.8 vs. 99.5%, HR=1.88, 95% CI: 0.56–6.31, P=0.307) and 5-year LCSS (99.9 vs. 99.6%, HR=1.76, 95% CI: 0.24–13.15, P=0.581). Conclusion: Intentional wedge resection is an appropriate choice for ≤2 cm GGO-dominant NSCLC.Keywords
This publication has 35 references indexed in Scilit:
- Stem-Branch: A Novel Method for Tracking the Anatomy During Thoracoscopic S9-10 SegmentectomyThe Annals of Thoracic Surgery, 2019
- Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503)The Lancet Respiratory Medicine, 2018
- Learning curve for port-access thoracoscopic anatomic lung segmentectomyThe Journal of Thoracic and Cardiovascular Surgery, 2018
- The Society for Translational Medicine: clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomyJournal of Thoracic Disease, 2017
- Sublobar Resection Margin Width Does Not Affect Recurrence of Clinical N0 Non‐small Cell Lung Cancer Presenting as GGO‐Predominant Nodule of 3 cm or LessWorld Journal of Surgery, 2016
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)Journal of Thoracic Oncology, 2011
- Sublobar Resection: A Movement from the Lung Cancer Study GroupJournal of Thoracic Oncology, 2010
- Margin and Local Recurrence After Sublobar Resection of Non-Small Cell Lung CancerAnnals of Surgical Oncology, 2007
- Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancerThe Annals of Thoracic Surgery, 1995